Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Methotrexate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Nordimet 12.5mg/0.5ml solution for injection pre-filled pens
0801030P0BFACFP
|
Nordimet | Methotrexate | Malignant Disease and Immunosuppression | 576 |
|
Nordimet 17.5mg/0.7ml solution for injection pre-filled pens
0801030P0BFAEFR
|
Nordimet | Methotrexate | Malignant Disease and Immunosuppression | 546 |
|
Methofill 15mg/0.3ml inj pre-filled injector
1001030U0BGADCC
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 531 |
|
Methotrexate 10mg/0.2ml inj pre-filled syringes
1001030U0AABFBF
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 513 |
|
Methotrexate 20mg/0.8ml inj pre-filled disposable devices
0801030P0AAFSFS
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 487 |
|
Methotrexate 22.5mg/0.45ml inj pre-filled disposable devices
1001030U0AABXBX
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 474 |
|
Methofill 25mg/0.5ml inj pre-filled injector
1001030U0BGAHCB
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 460 |
|
Methotrexate 7.5mg/0.15ml inj pre-filled disposable devices
1001030U0AABYBY
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 451 |
|
Methotrexate 25mg/1ml inj pre-filled disposable devices
0801030P0AAFUFU
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 404 |
|
Nordimet 22.5mg/0.9ml solution for injection pre-filled pens
0801030P0BFAGFT
|
Nordimet | Methotrexate | Malignant Disease and Immunosuppression | 369 |
|
Methotrexate 2mg/ml oral solution sugar free
1001030U0AACFCF
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 318 |
|
Methotrexate 15mg/0.6ml inj pre-filled disposable devices
0801030P0AAFQFQ
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 313 |
|
Nordimet 7.5mg/0.3ml solution for injection pre-filled pens
0801030P0BFAAFM
|
Nordimet | Methotrexate | Malignant Disease and Immunosuppression | 295 |
|
Methotrexate 12.5mg/0.25ml inj pre-filled syringes
1001030U0AABKBK
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 258 |
|
Methotrexate 17.5mg/0.35ml inj pre-filled syringes
1001030U0AABLBL
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 255 |
|
Methofill10mg/0.2ml inj pre-filled injector
1001030U0BGABCE
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 242 |
|
Methotrexate 25mg/1ml inj pre-filled syringes
0801030P0AAFGFG
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 218 |
|
Methotrexate 20mg/0.8ml inj pre-filled syringes
0801030P0AAFEFE
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 217 |
|
Methotrexate 22.5mg/0.45ml inj pre-filled syringes
1001030U0AABMBM
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 168 |
|
Methofill 20mg/0.4ml inj pre-filled syringes
1001030U0BGAPBH
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 152 |
|
Methotrexate 17.5mg/0.7ml inj pre-filled disposable devices
0801030P0AAFRFR
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 143 |
|
Methotrexate 15mg/0.6ml inj pre-filled syringes
0801030P0AAFKFK
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 138 |
|
Methotrexate 7.5mg/0.15ml inj pre-filled syringes
1001030U0AABEBE
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 137 |
|
Methotrexate 10mg/0.4ml inj pre-filled disposable devices
0801030P0AAFNFN
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 129 |
|
Zlatal 20mg/0.8ml solution for injection pre-filled syringes
0801030P0BEAAFE
|
Zlatal | Methotrexate | Malignant Disease and Immunosuppression | 118 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.